|
Volumn 27, Issue 3, 2002, Pages 195-198
|
Soya and health 2002 - Clinical evidence, dietetic applications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLESTEROL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYPOCHOLESTEROLEMIC AGENT;
ISOFLAVONE;
LINOLENIC ACID;
LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PHYTOESTROGEN;
PLACEBO;
POLYUNSATURATED FATTY ACID;
PROGESTERONE;
SAPONIN;
SOLGEN;
SOYBEAN PROTEIN;
ANIMAL EXPERIMENT;
BONE DENSITY;
BONE MINERAL;
BREAST CANCER;
CANCER RISK;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
COGNITION;
COMORBIDITY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DIETETICS;
DRUG POTENTIATION;
EVIDENCE BASED MEDICINE;
FEMALE;
FOOD INDUSTRY;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
LIPOPROTEIN BLOOD LEVEL;
MALE;
NONHUMAN;
NUTRITIONAL VALUE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SOYBEAN;
UNITED KINGDOM;
ANIMALIA;
GLYCINE MAX;
|
EID: 0036756093
PISSN: 01419684
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1467-3010.2002.00259.x Document Type: Conference Paper |
Times cited : (6)
|
References (0)
|